Critical Questions
September 26, 2022
Critical Questions
October 31, 2022
Treated or Not, COVID-19 Recurrence Seems Symptomatic for Some
April 13, 2020
…been anecdotally linked to COVID-19 infections. In a study published April 12, 2020 in the journal International Forum of Allergy & Rhinology, researchers at UC San Diego Health report the first empirical findings that strongly associate sensory loss with COVID-19, the respiratory disease caused by the novel coronavirus. “Based on…
November 3, 2022
Organoids Reveal How SARS-CoV-2 Damages Brain Cells — and a Potential Treatment
May 4, 2020
…of patients who contract COVID-19 require hospitalization, most are able to recover at home. UC San Diego Health now offers a specialized telemedicine clinic to help patients with COVID-19 return to good health in their homes under close observation of an infectious disease team. “Our goal is to help the…
August 9, 2021
Although COVID-19 is primarily treated as a respiratory disease, patients often experience neurological problems, such as headaches, anxiety, depression and cognitive issues, which can persist long after other symptoms have resolved. Some research has shown blood vessel damage and inflammation referred to as vasculitis in COVID-19 patients’ brains and central…
July 28, 2022
When reports showed COVID-19 vaccination rates were lower among racial/ethnic minority groups, most discussions focused on mistrust and misinformation among these populations or their reduced access to health care facilities. But new research from University of California San Diego and collaborating institutions has identified an additional barrier to equity: whether…
November 23, 2020
…common symptom of a COVID-19 infection, new research indicates the disease could also be associated with hypercoagulability, or increased tendency of the blood to clot. In a new study published November 20, 2020 in the journal EClinical Medicine by The Lancet, researchers from UC San Diego Health found that blood…
July 15, 2021
…of in-hospital death from COVID-19. The findings were published July 15, 2021 in PLOS ONE and expand upon prior research conducted at UC San Diego Health in 2020. Statins are commonly used to reduce blood cholesterol levels by blocking liver enzymes responsible for making cholesterol. They are widely prescribed: The…
April 29, 2020
…have therapeutic value for COVID-19 patients who have developed or at high risk of developing serious lung damage from SARS-CoV-2 infections. Tocilizumab, marketed as Actemra, is an immunosuppressive drug used primarily to treat rheumatoid arthritis and systemic juvenile idiopathic arthritis, a severe form of the disease in children. The monoclonal…